Crescent Biopharma (CBIO) Net Income by Year
Crescent Biopharma, Inc. reported a net loss of $153.9M in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $96.0M net loss. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters Crescent Biopharma, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CBIO Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
CBIO Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Crescent Biopharma, Inc. financials
Frequently Asked Questions
What was Crescent Biopharma, Inc.'s net income in fiscal year 2025?
Crescent Biopharma, Inc. reported a net loss of $153.9M in fiscal year 2025.
How fast is Crescent Biopharma, Inc.'s net income growing?
Crescent Biopharma, Inc. (CBIO) reported a $37.9M net loss in fiscal year 2024 and a $153.9M net loss in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
What is Crescent Biopharma, Inc.'s net income over the last twelve months?
Crescent Biopharma, Inc. (CBIO) reported a $96.0M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Crescent Biopharma, Inc.'s net income changed over the years?
Across the 14 fiscal years this page covers, Crescent Biopharma, Inc. (CBIO) net income went from $3.7M in fiscal year 2012 to -$153.9M in fiscal year 2025.
What was Crescent Biopharma, Inc.'s net income in the most recent quarter?
Crescent Biopharma, Inc. (CBIO) reported -$24.8M in net income in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Crescent Biopharma, Inc. (CBIO) reported on that line in every period on record.